EQS-Adhoc: SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO
|
EQS-Ad-hoc: SHOP APOTHEKE EUROPE N.V. / Key word(s): Personnel SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO Sevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. (SAE.DE), hereby announces that the supervisory board resolved today to propose Mr. Olaf Heinrich for election as member of the managing board and chairman of the managing board of the company at the next annual general meeting, which is expected to be held on 26 April 2023. It is intended that Mr. Olaf Heinrich will take office as a member of the managing board and chairman of the managing board on 1 August 2023 and will already be a consultant to the company in the period from 1 April 2023 to 31 July 2023.
15-March-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | SHOP APOTHEKE EUROPE N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | [email protected] |
| Internet: | www.shop-apotheke-europe.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y07 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1583653 |
| End of Announcement | EQS News Service |
|
|
1583653 15-March-2023 CET/CEST
Shop Apotheke Europe NV Aktie
Einige Buy-Einschätzungen dominieren bei Shop Apotheke Europe NV gegenüber Sell-Einschätzungen.
Ein positives, aber moderates Potenzial für Shop Apotheke Europe NV mit einem Kursziel von 145 € im Vergleich zu 136.4 €.
